BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 204 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $401,000 | -92.8% | 11,800 | -88.4% | 0.21% | -67.2% |
| Q4 2019 | $5,547,000 | +18.3% | 101,900 | -9.3% | 0.65% | +8.3% |
| Q3 2019 | $4,689,000 | -36.1% | 112,400 | -32.9% | 0.60% | +17.9% |
| Q2 2019 | $7,339,000 | -8.1% | 167,600 | +8.1% | 0.51% | +37.9% |
| Q1 2019 | $7,982,000 | +474.2% | 155,100 | +312.5% | 0.37% | +284.4% |
| Q4 2018 | $1,390,000 | – | 37,600 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 896,844 | $123,594,000 | 67.92% |
| RP Management, LLC | 1,111,111 | $153,122,000 | 64.09% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,075,402 | $286,011,000 | 40.64% |
| ARS Investment Partners, LLC | 463,392 | $63,860,000 | 5.86% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 300,373 | $41,394,000 | 4.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 80,348 | $11,073,000 | 4.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,900 | $19,282,000 | 4.30% |
| Avidity Partners Management LP | 1,140,000 | $157,103,000 | 3.33% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $27,562,000 | 3.17% |
| Eventide Asset Management | 1,635,000 | $225,319,000 | 2.88% |